Innsbruck Medical University – Developmental Therapeutics Review – Q4 2010

Date: December 1, 2010
Pages: 33
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: I45B014F8E1EN
Leaflet:

Download PDF Leaflet

Innsbruck Medical University – Developmental Therapeutics Review – Q4 2010
Innsbruck Medical University – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Innsbruck Medical University – Developmental Therapeutics Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Innsbruck Medical University – Brief company overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Innsbruck Medical University human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Innsbruck Medical University with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Innsbruck Medical University’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy
  • Evaluate Innsbruck Medical University’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Innsbruck Medical University in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Innsbruck Medical University’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Innsbruck Medical University.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Innsbruck Medical University and identify potential opportunities in those areas.
Innsbruck Medical University Snapshot
Innsbruck Medical University Overview
Key Information
Key Facts
Innsbruck Medical University – Research and Development Overview
Key Therapeutic Areas
Innsbruck Medical University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Innsbruck Medical University – Pipeline Products Glance
Innsbruck Medical University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Innsbruck Medical University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Innsbruck Medical University–Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Innsbruck Medical University – Drug Profiles
ATG + Tacrolimus + Tacrolimus + MMF therapy
  Product Description
  Mechanism of Action
  R&D Progress
Campath-1H + Tacrolimus
  Product Description
  Mechanism of Action
  R&D Progress
Pressyn
  Product Description
  Mechanism of Action
  R&D Progress
Bevacizumab + Irinotecan
  Product Description
  Mechanism of Action
  R&D Progress
Doxorubicin + Gemcitabine
  Product Description
  Mechanism of Action
  R&D Progress
Panitumumab + Cisplatin + Radiation Therapy
  Product Description
  Mechanism of Action
  R&D Progress
Sunitinib
  Product Description
  Mechanism of Action
  R&D Progress
SOCS-1 protein
  Product Description
  Mechanism of Action
  R&D Progress
Innsbruck Medical University – Pipeline Analysis
Innsbruck Medical University – Pipeline Products by Therapeutic Class
Innsbruck Medical University Pipeline Products By Target
Innsbruck Medical University – Pipeline Products by Route of Administration
Innsbruck Medical University – Pipeline Products by Molecule Type
Innsbruck Medical University – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 33

LIST OF TABLES

Innsbruck Medical University – Pipeline by Therapy Area and Indication, 2010
Innsbruck Medical University – Pipeline by Stage of Development, 2010
Innsbruck Medical University – Monotherapy Products in Pipeline, 2010
Innsbruck Medical University – Combination Treatment Modalities in Pipeline, 2010
Innsbruck Medical University – Phase III, 2010
Innsbruck Medical University - Phase II, 2010
Innsbruck Medical University - Pipeline By Therapeutic Class, 2010
Innsbruck Medical University - Pipeline By Target, 2010
Innsbruck Medical University – Pipeline By Route of Administration, 2010
Innsbruck Medical University – Pipeline By Molecule Type, 2010 30

LIST OF FIGURES

Innsbruck Medical University – Pipeline by Therapy Area and Indication, 2010
Innsbruck Medical University – Pipeline by Stage of Development, 2010
Innsbruck Medical University – Monotherapy Products in Pipeline, 2010
Innsbruck Medical University – Combination Treatment Modalities in Pipeline, 2010
Innsbruck Medical University – Pipeline By Therapeutic Class, 2010
Innsbruck Medical University - Pipeline By Target, 2010
Innsbruck Medical University – Pipeline By Route of Administration, 2010
Innsbruck Medical University – Pipeline By Molecule Type, 2010 30

Ask Your Question

Innsbruck Medical University – Developmental Therapeutics Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: